文献速递儿科影像神经US

重新评估极早产儿序贯颅脑超声筛查时机对神经发育结局的预测价值

Re-evaluating the timing of sequential cranial ultrasound screening in very preterm infants for predicting neurodevelopmental outcomes.
PubMed 文献 · Pediatr Radiol · 2024-12-04

该回顾性队列纳入2004年1月至2018年12月出生的656例极早产儿,比较三种基于颅脑超声的神经发育损害预测模型。仅含6周超声的模型与包含2周和6周超声的参考模型预测效能相当(AUC均为0.68),且优于仅含2周超声的模型(AUC 0.66),提示可省略2周超声。

要点

  • 仅6周超声模型与2周+6周参考模型预测36月龄神经发育损害的AUC均为0.68。
  • 仅6周超声模型AIC最低(766),优于参考模型(769)和仅2周模型(784)。
  • 作者认为同时做2周和6周超声是多余的,可取消2周超声。

核心结论

  • 在极早产儿队列中,仅含6周超声的模型与包含2周和6周超声的参考模型预测36月龄矫正年龄神经发育损害的效能相当,取消2周超声对预测无影响。

研究设计与样本

  • 回顾性队列研究,纳入2004年1月至2018年12月出生的656例极早产儿(220-306周),均于矫正年龄36月龄接受神经发育评估。

诊断标准与关键数值

  • 仅6周超声模型预测36月龄神经发育损害的AUC为0.68(95%CI 0.63-0.72),参考模型(2周+6周)AUC为0.68(95%CI 0.63-0.72),仅2周模型AUC为0.66(95%CI 0.61-0.70)。仅6周模型AIC为766,参考模型AIC为769,仅2周模型AIC为784。

临床应用与阅片要点

  • 作者认为同时进行2周和6周超声是多余的,可取消2周超声,以促进医疗资源的合理分配与管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Accurate and early prediction of neurodevelopmental impairment is a crucial endeavor in caring for very preterm infants (<31 weeks' gestation). Sequential cranial ultrasound is the standard of care for the evaluation of preterm brain injury. However, there is no consensus on the timing and frequency of ultrasound screening. At Izaak Walton Killam (IWK) Health Centre, Halifax, Canada, four-time points for routine ultrasound of very preterm infants are performed at weeks 1, 2, 6, and term age. The hypothesis behind this work is that a three-time-point model will be appropriate for neurodevelopmental impairment prognostication.

MATERIALS AND METHODS: In this retrospective cohort, all very preterm infants (220-306 weeks) born between January 2004 and December 2018 with a neurodevelopmental assessment at 36 months corrected age were included. Three prediction models of neurodevelopmental impairment were compared: 1. A reference model including the gestational age, infant sex, and 2-week and 6-week ultrasound 2. A model including the gestational age, infant sex, and 6-week ultrasound 3. A model including the gestational age, infant sex, and 2-week ultrasound RESULTS: Of 786 eligible preterm infants born during the study period, 656/786 survivors were included in the analysis (mean gestational age 275 weeks, mean birth weight 1,133 g, and 55% male infants). At 36 months of corrected age, 30% developed neurodevelopmental impairment. All three models provided comparable discrimination areas under the curve (AUC) of neurodevelopmental impairment at 36 months of corrected age. Both the 6-week and the reference model had similar AUC of 0.68 (95% CI 0.63-0.72) and were not noticeably different from the 2-week model (AUC 0.66 (95% CI 0.61-0.70)). The 6-week model provided the best prediction with the lowest Akaike information criterion (AIC) of 766 for the 6-week-only model, AIC 769 for combined weeks 2 and 6 (reference model), and AIC 784 for the 2-week-only model.

CONCLUSION: In this cohort of very preterm infants, a model including 6-week ultrasound only was comparable to a reference model combining 2-week and 6-week ultrasound and showed nearly identical predictive performance of neurodevelopmental impairment at 36 months corrected age across a broad set of metrics; thus, it is redundant to do both the 2-week and 6-week ultrasound.

CLINICAL RELEVANCE STATEMENT: Late ultrasound at 6 weeks of age provided comparable diagnostic and prognostic information to a reference model combining 2-week and 6-week ultrasound and, if anything, was slightly superior to the 2-week ultrasound model, across a broad set of metrics. The 2-week ultrasound can be eliminated with no impact on the prediction of neurodevelopmental impairment at 36 months, promoting prudent resource allocation and stewardship in healthcare.

来源:Pediatr Radiol,查看原文。版权归原作者所有。

引用

  1. Ramdass S, Disher T, Vincer M, et al. Re-evaluating the timing of sequential cranial ultrasound screening in very preterm infants for predicting neurodevelopmental outcomes. Pediatr Radiol. 2024. PMID: 39630240. doi:10.1007/s00247-024-06105-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。